Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
Compare Balance Sheet Results of Norris Medicines
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
9.93
8.76
1.17
13.36%
Share Warrants & Outstandings
Total Reserve
-24.79
5.63
-30.42
-540.32%
Shareholder's Funds
-14.87
14.39
-29.26
-203.34%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
18.53
0.06
18.47
30,783.33%
Secured Loans
0.00
0.04
-0.04
-100.00%
Unsecured Loans
18.53
0.02
18.51
92,550.00%
Deferred Tax Assets / Liabilities
-0.90
-0.14
-0.76
-542.86%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.01
-0.01
-100.00%
Total Non-Current Liabilities
17.62
-0.08
17.70
22,125.00%
Current Liabilities
Trade Payables
2.57
0.34
2.23
655.88%
Other Current Liabilities
1.79
0.25
1.54
616.00%
Short Term Borrowings
3.05
0.00
3.05
0.00%
Short Term Provisions
2.74
0.00
2.74
0.00%
Total Current Liabilities
10.15
0.60
9.55
1,591.67%
Total Liabilities
12.91
14.91
-2.00
-13.41%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.76
1.41
26.35
1,868.79%
Less: Accumulated Depreciation
22.49
1.26
21.23
1,684.92%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.27
0.15
5.12
3,413.33%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.01
0.00
0.01
0.00%
Long Term Loans & Advances
1.29
0.19
1.10
578.95%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
6.57
0.35
6.22
1,777.14%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
4.13
2.80
1.33
47.50%
Sundry Debtors
1.41
8.59
-7.18
-83.59%
Cash and Bank
0.04
0.34
-0.30
-88.24%
Other Current Assets
0.74
0.11
0.63
572.73%
Short Term Loans and Advances
0.02
2.73
-2.71
-99.27%
Total Current Assets
6.34
14.56
-8.22
-56.46%
Net Current Assets (Including Current Investments)
-3.81
13.96
-17.77
-127.29%
Total Current Assets Excluding Current Investments
6.34
14.56
-8.22
-56.46%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
12.91
14.91
-2.00
-13.41%
Contingent Liabilities
1.33
0.79
0.54
68.35%
Total Debt
21.58
0.06
21.52
35,866.67%
Book Value per share (adjusted)
-14.98
1.64
-16.62
-1,013.41%
Annual - Borrowings
Borrowings 21.58 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.28% vs 0.56% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -8.98% vs -10.51% in Mar 2024
Annual - Investments
Investments 0.01 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 6.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 3.26% vs 24.80% in Mar 2024
